Publication & Citation Trends
Publications
155 total
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Cited by 606
OpenAlex
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
Cited by 665
OpenAlex
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival PDF
Cited by 581
OpenAlex
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL PDF
Cited by 232
OpenAlex
A Comprehensive Analysis of Common Copy-Number Variations in the Human Genome PDF
Cited by 522
OpenAlex
<i>BCL2</i> Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma PDF
Cited by 303
OpenAlex
BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma PDF
Cited by 279
OpenAlex
Research Topics
Lymphoma Diagnosis and Treatment
(72)
Chronic Lymphocytic Leukemia Research
(34)
Acute Myeloid Leukemia Research
(25)
Viral-associated cancers and disorders
(22)
Genomic variations and chromosomal abnormalities
(15)
Affiliations
University of British Columbia Hospital
BC Cancer Agency
University of British Columbia
Sanford Burnham Prebys Medical Discovery Institute
Vancouver Hospital and Health Sciences Centre